UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003252
Receipt number R000003933
Scientific Title Phase II trial of DIF drug as adjuvant therapy after curative resection of colon cancer - Investigation of risk facter for colon cancer-
Date of disclosure of the study information 2010/03/01
Last modified on 2010/02/24 19:15:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II trial of DIF drug as adjuvant therapy after curative resection of colon cancer - Investigation of risk facter for colon cancer-

Acronym

Phase II trial of DIF drug as adjuvant therapy after curative resection of colon cancer

Scientific Title

Phase II trial of DIF drug as adjuvant therapy after curative resection of colon cancer - Investigation of risk facter for colon cancer-

Scientific Title:Acronym

Phase II trial of DIF drug as adjuvant therapy after curative resection of colon cancer

Region

Japan


Condition

Condition

Colon cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

YES


Objectives

Narrative objectives1

To explore effectiveness and saftety of UFT/LV or TS-1 followed by UFT for prevention of stage II/III colon cancer reccurence.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Phase II


Assessment

Primary outcomes

Relapse free survival

Key secondary outcomes

Overall survival,Compliance, Relation of risk facter, Measurement of anticancer drug-sensitive facter


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -participants are blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

UFT/LV
UFT 300mg/m2/day
LV 750mg/day
for 28 days followed by a 7-day rest period (one cycle=5 weeks)X5 cycle

or
TS-1
80mg/m2/day
for 28 days followed by a 14-day rest period (one cycle = 6 weeks) X 4 cycle

UFT
400mg/body/day
450mg/body/day
for 1.5 years treatind UFT/LV or TS-1

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) histopathologically proven colon cancer
2) pathological stage 2 (high risk),3
3) resection of histological curability A was performed
4) ECOG PS 0-2
5) 20-80 years old
6) no prior chemotherapy and radiotherapy
7) adequate organ function
8) Written informed consent

Key exclusion criteria

1) Contraindications of using UFT, LV, TS-1
2) active double cancer except ca. in situ
3) Severe postoperative complication
4) Serious coexisting illness
a)uncontrolled diabetes mellitus
b)uncontrolled hypertension
c)history of myocardial infarction, unstable angina within 6 months prior to the registration severe
d)liver cirrhosis
e)pulmonary dysfunction
5) pregnant or nursing patient or with intent to bear baby
6) mental disorder or psychiatric symptom
7) HIV infection
8) Disqualified by attending doctor

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kimikazu Hamano

Organization

Yamaguchi University

Division name

Department of Surgery and Clinical Science

Zip code


Address

1-1-1, Minamikogushi, Ube, Yamaguchi, Japan

TEL

0836-22-2261

Email



Public contact

Name of contact person

1st name
Middle name
Last name Tadahiko Enoki

Organization

Yamaguchi University

Division name

Department of Surgery and Clinical Science

Zip code


Address

1-1-1, Minamikogushi, Ube, Yamaguchi, Japan

TEL

0836-22-2261

Homepage URL

http://ds.cc.yamaguchi-u.ac.jp/~surg-1/

Email

surg-1@yamaguchi-u.ac.jp


Sponsor or person

Institute

Yamaguchi University
Department of Srgery and Clinical Science

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

小野田市民病院(山口県)
済生会下関総合病院(山口県)
済生会山口総合病院(山口県)
周東総合病院(山口県)
光市立大和総合病院(山口県)
徳山総合病院(山口県)
長門総合病院(山口県)
萩市民病院(山口県)
光市立光総合病院(山口県)
三田尻病院(山口県)
山口県立総合医療センター(山口県)
山口労災病院(山口県)
愛媛労災病院(愛媛県)
下関医師会病院(山口県)


Other administrative information

Date of disclosure of the study information

2010 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2008 Year 07 Month 03 Day

Date of IRB


Anticipated trial start date

2008 Year 07 Month 01 Day

Last follow-up date

2015 Year 06 Month 01 Day

Date of closure to data entry

2015 Year 08 Month 01 Day

Date trial data considered complete

2015 Year 09 Month 01 Day

Date analysis concluded

2015 Year 10 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 02 Month 24 Day

Last modified on

2010 Year 02 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003933


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name